Status:
WITHDRAWN
Efficacy of Probiotics for Parkinson Disease (PD)
Lead Sponsor:
Changhua Christian Hospital
Collaborating Sponsors:
Bened Biomedical Co., Ltd.
Conditions:
Parkinson's Disease (PD)
Movement Disorders
Eligibility:
All Genders
41-80 years
Phase:
NA
Brief Summary
In previous clinical studies, PS128 has been reported to ameliorate motor deficits in Parkinson's disease (PD). PS23 has been reported to delay some age-related disorders. On the basis of previous an...
Detailed Description
The gut microbiota plays important roles in gastrointestinal homeostasis, essential physiological processes and CNS function, and affects the gut-brain axis via neural, immune and endocrine pathways g...
Eligibility Criteria
Inclusion
- The age between 41-80 years old and at least the elementary education level.
- Diagnosed as a patient with Parkinson's disease of modified Hoehn and Yahr Stage between 1 and 3 as rated.
Exclusion
- Diagnosed before 40 years old.
- Used probiotic products in powder, capsule, or tablet form within four weeks.
- Have taken antibiotics within four weeks.
- Those who are not suitable to participate in the research are judged by PI.
Key Trial Info
Start Date :
November 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2026
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06118294
Start Date
November 8 2023
End Date
October 30 2026
Last Update
April 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhua Christian Hospital (CCH)
Changhua, Taiwan, 50006